Cartesian Therapeutics Inc (NASDAQ: RNAC)

Analyst Insights

Cartesian Therapeutics Inc (RNAC) last year’s performance of -61.25% is a clear signal for an entertaining trading season.

Sana Meer

On Tuesday, Cartesian Therapeutics Inc (NASDAQ: RNAC) was 7.26% up from the session before settling in for the closing price ...

Top Picks

Now that Cartesian Therapeutics Inc’s volume has hit 0.81 million, investors get a glimpse of its size.

Zack King

On Tuesday, Cartesian Therapeutics Inc (NASDAQ: RNAC) opened higher 17.56% from the last session, before settling in for the closing ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.